BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
3Y CAGR-37.8%
5Y CAGR+12.0%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-37.8%/yr
Annual compound
5Y CAGR
+12.0%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 32.67 | +11.6% |
| 2024 | 29.26 | -72.9% |
| 2023 | 108.03 | -20.2% |
| 2022 | 135.44 | +153.7% |
| 2021 | -252.11 | -1458.0% |
| 2020 | 18.56 | +102.9% |
| 2019 | -634.76 | -225.1% |
| 2018 | -195.27 | -46.9% |
| 2017 | -132.89 | -509.1% |
| 2016 | -21.82 | - |